STAT

JUNE 24, 2024

Suicide rates in the United States increased approximately 36% between 2000 and 2022, according to updated data from the National Center for Health Statistics. Suicide was responsible for just under 50,000 deaths in 2022 (the last year with complete statistics) — an all-time high. As this appalling trend continues, offering mental health assessments and care in primary care settings could help save lives.

361

361

ALiEM - Pharm Pearls

JUNE 24, 2024

With some things in life, speed is everything. Adenosine is one of those things. With an ultrafast half-life estimated to be between 0.6 to 10 seconds [1], parenterally administered adenosine needs to reach the cells of the AV-node and cardiac pacemaker cells in an expedited fashion to facilitate the termination of supraventricular tachycardias (SVTs).

Hospitals 286

Hospitals 286

STAT

JUNE 24, 2024

Bird flu snapshot: This is the second installment in a series of regular updates on H5N1 avian flu that STAT is publishing on Monday mornings. To read future updates you can also subscribe to STAT’s Morning Rounds newsletter. As the H5N1 outbreak in dairy herds approaches the three-month mark, America’s top animal health official is calling on farmers to step up the use of personal protective equipment, limit traffic onto their farms, and increase cleaning and disinfection practice

359

359

PharmaVoice

JUNE 24, 2024

With a career focused on striking deals, Kaan Cartel is hoping to lead the Flagship-backed biotech with an mRNA platform into its next phase of growth.

268

268

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

JUNE 24, 2024

Alnylam Pharmaceuticals said Monday that its treatment for an increasingly common heart condition cut the risk of death and recurrent cardiovascular complications in a key Phase 3 study, paving the way for the likely approval of the drug. Specifically, on that composite primary endpoint, the drug, called vutrisiran, reduced the risk by 28% compared with placebo in the overall trial population, which included some people who were already taking a treatment for the disease considered the standard

Labelling 347

Labelling 347

pharmaphorum

JUNE 24, 2024

Explore how digital twins are transforming healthcare and drug discovery, with success stories showcasing their impact in the biopharma industry. Learn about their journey from concept to real-world applications.

122

122

Pharmaceutical Technology

JUNE 24, 2024

The osteoporosis market is expected to grow at a compound annual growth rate of 5.4% from 2023 to 2032, reaching $17.9bn across the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) by the end of this forecast period, according to leading data and analytics company GlobalData’s recent report: Osteoporosis: Seven-Market Drug Forecast and Market Analysis.

Compounding 105

Compounding 105

STAT

JUNE 24, 2024

When a new medical device hits the market, there’s typically still some uncertainty about whether it works. Device makers generally do not have to submit as much, or as rigorous, clinical data to the Food and Drug Administration as their biotech counterparts. Once FDA regulators decide a device is safe and effective, companies and researchers then attempt to track how the device performs in the real world.

Hospitals 328

Hospitals 328

pharmaphorum

JUNE 24, 2024

Daiichi Sankyo has a second approval in Japan for Ezharmia, its first-in-class dual EZH1 and EZH2 inhibitor, as a treatment for relapsed or refractory peripheral T-cell lymphoma (PTCL).Ezharmia (valemetostat tosylate) remains the first and only drug in the class to be approved for marketing around the world, having been cleared in Japan in 2022 for relapsed or refractory adult T-cell leukaemia/lymphoma (ATL).

103

103

STAT

JUNE 24, 2024

On Tuesday, shares of Grail, the liquid biopsy company that hopes that its test, Galleri, will be widely used to screen for cancer, will become a publicly traded stock (with the ticker GRAL) that any investor can buy or sell on the Nasdaq. That will, in a sense, end a long, strange trip that has taken a decade. Grail was spun out by the DNA sequencing giant Illumina in 2015.

315

315

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

JUNE 24, 2024

Fenofibrate, a decades-old drug used to lower cholesterol levels, has been shown to reduce the progression of diabetic retinopathy in a large-scale trial.

Diabetes 108

Diabetes 108

STAT

JUNE 24, 2024

New research shows that, in spite of recommendations discouraging use of aspirin in primary prevention of cardiovascular disease among older adults, nearly a third of adults 60 years and older are still using it for this very purpose. The study , published on Monday in Annals of Internal Medicine, found that 18.5 million adults 60 and older without cardiovascular disease reported using preventative aspirin in 2021.

297

297

Drug Patent Watch

JUNE 24, 2024

The 505(b)(2) regulatory pathway provides an attractive avenue for drug developers to bring new products to market by leveraging existing data on approved drugs. This pathway allows modifications and improvements to be made to existing drugs, while potentially reducing development costs and timelines compared to the traditional new drug application (NDA) route.

Drug Development 95

Drug Development 95

STAT

JUNE 24, 2024

The results of a randomized controlled trial published Monday showed oral ketamine tablets were safe and effective for patients with treatment-resistant depression — the latest attempt by researchers to rigorously evaluate psychedelic drugs’ role in treating conditions like depression, anxiety and post-traumatic stress disorder. In the Phase 2 trial, the results of which were detailed in Nature Medicine , patients who took extended release ketamine tablets at an 180mg dosage twice

Dosage 296

Dosage 296

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

The Pharmacist

JUNE 24, 2024

A ‘quantity of controlled drugs’ have been reported stolen from a pharmacy in South Devon, after a break-in during the early hours of the morning. Police were called at around 1.25 am to the Well Pharmacy branch in Churchill Court, Brixham, on Wednesday 19 June. The burglars caused damage and gained entry to the pharmacy, before […] The post Controlled drugs reported stolen from Devon pharmacy appeared first on The Pharmacist.

92

92

STAT

JUNE 24, 2024

VALLETTA, Malta — The most sweeping corruption trial in the history of this Mediterranean country kicked off with a former prime minister and a host of top government officials parading through a phalanx of police into a courthouse. Hundreds of onlookers crammed narrow cobblestone streets, some screaming of their distrust in the government and disdain for the men who allegedly used their power to line their pockets.

Hospitals 257

Hospitals 257

Pharmaceutical Commerce

JUNE 24, 2024

A study examines the economical validity of using this therapy as a treatment for unresectable stage III non–small cell lung cancer.

105

105

STAT

JUNE 24, 2024

Good morning, everyone, to another working week. We hope the weekend respite was relaxing and inspiring, because that oh-so familiar routine of online meetings, deadlines, and what-not has predictably returned. But what can you do? The world, such as it is, continues to spin. So time to give it a nudge in a better direction with a cup or more of stimulation.

Diabetes 249

Diabetes Packaging 249

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

JUNE 24, 2024

Lupin announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility in Somerset, New Jersey, with a Voluntary Action Indicated (VAI) status. The facility was inspected from May 7 to May 17, 2024. “We are very pleased to have received the EIR with a satisfactory VAI status for our Somerset facility.

101

101

STAT

JUNE 24, 2024

The federal government has cemented a key part of its strategy for making patients’ medical records transfer easier: setting disincentives for providers engaging in what’s known as “information blocking.” In a final rule released Monday, the Health and Human Services Department outlined financial consequences for hospitals, clinicians, and accountable care organizations if they interfere with or discourage the access or use of electronic health information, including

Medical Records 243

Medical Records Hospitals 243

Pharmaceutical Technology

JUNE 24, 2024

Big pharma and their packaging partners are collaborating to cut emissions and deliver more sustainable solutions for injectables.

Packaging 97

Packaging 97

STAT

JUNE 24, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. On top of today’s Alnylam news, we have Congress gearing up to vote on Medicare coverage for multi-cancer screenings and obesity drug coverage. Also, updates on Vertex’s type 1 diabetes cell therapy, and a push for phage therapy.

Diabetes 220

Diabetes Drug Pricing Drug Development 220

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

JUNE 24, 2024

The manifesto calls on the next UK government to make dementia a key health priority

113

113

pharmaphorum

JUNE 24, 2024

Alnylam shares spike after vutrisiran aces HELIOS-B trial in ATTR-cardiomyopathy, setting up regulatory filings

107

107

Pharma Times

JUNE 24, 2024

The initiative aims to improve African pandemics, outbreaks, preparedness and responses

Vaccines 102

Vaccines 102

Express Pharma

JUNE 24, 2024

Sun Pharma announced the successful completion of the merger of Taro Pharmaceutical Industries with its subsidiary. As part of this merger, Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliates. As a result of the merger, Taro is now a private company and wholly owned by Sun Pharma.

88

88

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

European Pharmaceutical Review

JUNE 24, 2024

SGS customers now have easier access to biopharmaceutical insights as the Birsfelden, Switzerland lab adds a stability studies service. The lab now offers reliable, cost-efficient stability testing, including sample storage and related analytical services under controlled conditions, adhering to ICH Q5C guidelines. SGS project managers oversee studies.

69

69

pharmaphorum

JUNE 24, 2024

Bristol-Myers Squibb’s KRAS inhibitor Krazati has been approved for a second indication, colorectal cancer

99

99

The Pharmacist

JUNE 24, 2024

‘A number’ of community pharmacies will be commissioned by NHS England (NHSE) to provide the respiratory syncytial virus (RSV) vaccine to older adults from this autumn. A letter published today by NHSE and the UK Health Security Agency announced the introduction of a new RSV vaccination programme from 1 September 2024, for older adults and […] The post 'A number' of pharmacies to provide RSV vaccine in new NHS programme appeared first on The Pharmacist.

Vaccines 75

Vaccines Community Pharmacies 75

EMCrit Project

JUNE 24, 2024

a unique ventilatory mode unfortunately only available on Hamilton vents EMCrit Project by Scott Weingart, MD FCCM.

81

81

pharmaphorum

JUNE 24, 2024

Novo Nordisk boosts manufacturing capacity for GLP-1 drugs again, unveiling a $4.

101

101